Companies: 10,795·Total market cap: $144.5T
Comera Life Sciences Holdings, Inc.

Comera Life Sciences Holdings, Inc.

CMRAOTCHealthcare● Active
$0.00
+$0.00(+9900.00%)
Market Cap$3074
P/E Ratio
52W High$0.0002
52W Low$0.0001
Overview

Comera Life Sciences Holdings, Inc. (CMRA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CMRA · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.49cmra eps ttm · cmra earnings per shareEarnings history
PE Ratio (TTM)cmra pe ratio ttm · cmra price to earningsPE Ratio deep dive
Revenue (TTM)$1.0Mcmra revenue ttm · cmra annual revenueFull revenue history
Dividend YieldNo Dividenddoes cmra pay dividends · cmra dividend yieldDividend history
Shares Outstanding10.5Mcmra shares outstanding · cmra floatShares outstanding history
Next EarningsTBAcmra earnings date · cmra next earningsEarnings history

Financial Snapshot

Full Financials
FY 2022Revenue$633102.00▲ +97.95% YoY
202020212022
comera life sciences holdings, inc. revenue · cmra revenue 2022
FY 2022Net Income-$18.0M▼ 230.24% YoY
202020212022
comera life sciences holdings, inc. net income · cmra profit 2022
FY 2022EPS$-1.76▼ 506.90% YoY
202020212022
cmra eps · comera life sciences holdings, inc. earnings per share 2022
TTM:Revenue: $1.0MNet Income: -$9.0MEPS: $-0.49View income statement →

Stock Performance

Full History
1D+9900.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+9900.00%
1Y-50.00%
5Y-100.00%

About Comera Life Sciences Holdings, Inc.

CEOMichael G. Campbell
IPO DateDec 21, 2020
Employees12
CountryUS

Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platfor…

what is comera life sciences holdings, inc. · cmra stock overview · comera life sciences holdings, inc. company profile · who is comera life sciences holdings, inc. ceo · cmra OTC · comera life sciences holdings, inc. headquarters · comera life sciences holdings, inc. business segments

About Stock Overview & Key Data

Comera Life Sciences Holdings, Inc. (CMRA) is a Healthcare company in the Biotechnology industry, listed on OTC since Dec 21, 2020. As of the latest trading session, CMRA stock price is $0.00, with a market capitalization of $3,074. The stock has returned -50.00% over the past 12 months and +9900.00% year-to-date.

In fiscal year 2022, Comera Life Sciences Holdings, Inc. reported revenue of $633102.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Comera Life Sciences Holdings, Inc. (CMRA) stock price is $0.00. The stock is traded on OTC under the ticker symbol CMRA. The 52-week range is $0.00 – $0.00.

CMRA stock priceCMRA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice